drugset / Trial / NCT05864573
Study of ZGGS15 in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is a multi-center, open-label, Phase 1 clinical study of ZGGS15 for the treatment of patients with advanced solid tumors.
Timeline
- Start
- 2023-07-19
- Primary completion
- 2025-06-26
- Completion
- 2025-06-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ZGGS15 | Unknown | 0.3 mg/kg | Intravenous |
| Subject | ZGGS15 | Unknown | 1 mg/kg | Intravenous |
| Subject | ZGGS15 | Unknown | 3 mg/kg | Intravenous |
| Subject | ZGGS15 | Unknown | 10 mg/kg | Intravenous |
| Subject | ZGGS15 | Unknown | 20 mg/kg | Intravenous |
| Subject | ZGGS15 | Unknown | 30 mg/kg | Intravenous |